在慢性阻塞性肺病中,TRPC6通道调节了气道重塑,导致右心衰竭
Kun Liu1, Qi-Ming Tan2, Jie Zhang1
1Department of Cardiology, The First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China.
Antioxidants & redox signaling
|December 5, 2024
概括
这项研究表明,尼古丁通过TRPC6和NF-κB信号传递增加了慢性阻塞性肺病 (COPD) 的呼吸道光滑肌肉细胞增殖. miR-135a/b-5p对抗这些影响,为COPD提供潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
背景情况:
- 在慢性阻塞性肺病 (COPD) 中,短暂受体潜在通道TRPC6的作用尚不清楚.
- 呼吸道光滑肌肉 (ASM) 改造是COPD的关键特征,但潜在的分子机制需要进一步阐明.
研究的目的:
- 在COPD的背景下,研究TRPC6在人类呼吸道光滑肌细胞 (HASMCs) 中的作用和信号机制.
- 探索尼古丁和microRNA-135a/b-5p (miR-135a/b-5p) 对HASMC中TRPC6表达和功能的影响.
主要方法:
- 定量PCR和西式斑点测试用于评估TRPC6mRNA和蛋白质表达.
- 同免疫沉和电泳运动转移试验,以调查NF-κB的参与.
- 路西法酶记者测定证实了TRPC6.6的miR-135a/b-5p调节.
- 烟草诱导的呼吸道改造的小鼠模型中的免疫组织化学.
主要成果:
- 尼古丁暴露增加了HASMC中的TRPC6表达和转录活性,由NF-κB介导.
- 在HASMC中,miR-135a/b-5p被确定为TRPC6表达的负调节者.
- 在小鼠中,香烟烟雾引起的气道改造显示了光滑肌肉细胞增殖和质量的增加,与TRPC6介导的流入有关.
- 治疗miR-135a/b-5p改善了这些效应,无论是体外还是体外.
结论:
- 尼古丁通过NF-κB和TRPC6信号促进了HASMC的扩散和迁移.
- 吸入香烟烟雾有助于通过改变TRPC6活性来重塑呼吸道,这种活动可以通过miR-135a/b-5p进行调节.
- TRPC6和miR-135a/b-5p代表了管理COPD呼吸道光滑肌肉重塑的潜在治疗点.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
141
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
141
01:20Mitral Regurgitation I: Introduction
2
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
2
01:20COPD: Pathogenesis and Clinical Features
232
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
232